Literature DB >> 18000966

Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?

Yuhua Sun1, Yuejin Yang, Weidong Pei, Yongjian Wu, Jinglin Zhao.   

Abstract

BACKGROUND: High-density lipoprotein (HDL) could enhance inflammation in atherogenesis when inflammatory response is present, and the activity of paraoxonase and antioxidant in HDL in the elderly is significantly decreased. There might be a different role for high-density lipoprotein cholesterol (HDL-C) between different age groups in patients with coronary heart disease (CHD).
METHODS: For this study, 225 inpatients with CHD (coronary atherosclerosis stenosis >/= 50% on >/= 1 major coronary arteries by coronary angiography), and 80 without CHD; 120 resting unstable angina patients, and 68 with stable angina were consecutively recruited. Risk factors were analyzed for CHD and resting unstable angina.
RESULTS: High-density lipoprotein cholesterol in resting unstable angina was higher than that in stable angina (1.24 +/- 1.05 versus 1.05 +/- 0.29 mmol/L, p = 0.032). After adjustment for age, sex, physical inactivity, hypertension, diabetes, C-reactive protein, triglycerides, total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) the adjusted odds ratio (OR) (95% CI) of resting unstable angina was 10.19 (2.18-47.6, p = 0.003) for HDL-C. Risk factors were further investigated in different age groups. Adjusted OR of CHD associated with HDL-C in < 55-year-old group was 0.09 (0.01-0.66, p = 0.018), in >/= 55-year-old group it was 0.55 (0.08-3.82, p > 0.05). Adjusted OR of resting unstable angina associated with high HDL-C was 19.24 (2.86-129.4, p = 0.002) in patients aged >/= 55 years.
CONCLUSIONS: Elevated HDL-C might be an independent risk factor for resting unstable angina, even though HDL-C could play a much more important role in protection against coronary stenosis in younger or middle-aged persons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000966      PMCID: PMC6653671          DOI: 10.1002/clc.20137

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  20 in total

1.  Transient microvascular vasoconstriction: a possible cause of unstable angina.

Authors:  G Niccoli; G Renda; D Cianflone; F Crea
Journal:  Ital Heart J       Date:  2000-05

2.  Correlates of high HDL cholesterol among women with coronary heart disease.

Authors:  V Bittner; J A Simon; J Fong; R S Blumenthal; K Newby; M L Stefanick
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

3.  Study of factors influencing the decreased HDL associated PON1 activity with aging.

Authors:  Ildiko Seres; Gyorgy Paragh; Elaine Deschene; Tamas Fulop; Abdelouahed Khalil
Journal:  Exp Gerontol       Date:  2004-01       Impact factor: 4.032

4.  Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene.

Authors:  B Agerholm-Larsen; B G Nordestgaard; R Steffensen; G Jensen; A Tybjaerg-Hansen
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

5.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Authors:  H B Rubins; S J Robins; D Collins; C L Fye; J W Anderson; M B Elam; F H Faas; E Linares; E J Schaefer; G Schectman; T J Wilt; J Wittes
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

6.  Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Authors:  S J Robins; D Collins; J T Wittes; V Papademetriou; P C Deedwania; E J Schaefer; J R McNamara; M L Kashyap; J M Hershman; L F Wexler; H B Rubins
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

7.  Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging.

Authors:  C Milochevitch; A Khalil
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2001 Nov-Dec       Impact factor: 4.006

8.  Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese.

Authors:  Lung-An Hsu; Yu-Lin Ko; Kuang-Hung Hsu; Yu-Hsien Ko; Ying-Shiung Lee
Journal:  Hum Genet       Date:  2001-11-10       Impact factor: 4.132

Review 9.  Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm.

Authors:  Kunihisa Miwa; Masatoshi Fujita; Shigetake Sasayama
Journal:  Heart Vessels       Date:  2005-02       Impact factor: 2.037

10.  A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly.

Authors:  J D Curb; R D Abbott; B L Rodriguez; K Masaki; R Chen; D S Sharp; A R Tall
Journal:  J Lipid Res       Date:  2004-02-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.